Study warns of increasing Rocky Mountain spotted fever cases among children in California

Recent cases of Rocky Mountain spotted fever in children underscore the effectiveness of mcf-NGS for early detection and timely treatment in non-endemic areas.

FDA’s START and CoGenT pilot programmes: Streamlining rare disease drug approvals

This week, at the J.P. Morgan Healthcare Conference and the Biotech Showcase, discussions underscored the growing focus on innovation in cell and gene therapies. Against

January 20, 2025

How Telehealth and AI Are Transforming Access and Affordability

Avihai Sodri, CEO, Antidote Health Each year, the financial barriers to healthcare continue to become more pronounced in the US. For example, the health expenditure per

April 3, 2024

New Option Approved for Erosive Esophagitis

The FDA approved vonoprazan (Voquezna) for all grades of erosive gastroesophageal reflux disease (GERD) and heartburn relief associated with the condition, Phathom Pharmaceuticals announced on

November 3, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.